revive

Interviews and expert commentary tagged “revive” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Levosimendan Improves Heart Failure Progression
Audio Journal of Oncology

Levosimendan Improves Heart Failure Progression

Milton Packer In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas. [audio:https://ww

16 November 2005
0:00
COMMENTS
Audio Journal of Oncology

COMMENTS

Gordon Tomaselli Gordon Tomaselli commented on Milton Packer’s findings at the Dallas meeting of the American Heart Association. [audio:https://www.audiomedica.com/podcasting/aha2005/Gordon_Toma

16 November 2005
0:00
← Browse all episodes